CorNeat Vision
A new era of medical devices
StartupCorNeat Vision is a Ra'anana-based startup in the Health Tech & Life Sciences sector, established in 2015. A new era of medical devices. The company has raised a total of $18.77M across 7 funding rounds, currently at the B stage. CorNeat Vision was founded by Gilad Litvin and Almog Aley-raz. Key investors include Guangzhou Sino-Israel Biotech Investment Fund (GIBF), Undisclosed Investor(s). The company has 11-50 employees. Core technologies: Materials & Substances, Implants.
With $18.77M in total funding, CorNeat Vision is a B-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageB
- ProductReleased
- ModelB2B
- Employees11-50
- HQRa'anana
- DistrictCenter District
- Last Round$2.5M
- Guangzhou Sino-Israel Biotech Investment Fund (GIBF)Lead
- Undisclosed Investor(s)
Gilad LitvinCo-founder, Chairman, Chief Medical Officer
Almog Aley-razCo-founder & CEO & VP R&D
13 articles covered by sources including www.prnewswire.com,
nocamels.com,
www.calcalistech.com,
www.jpost.com,
www.israel21c.org.
What does CorNeat Vision do?
CorNeat Vision is a medical device company developing and marketing novel, permanent and tissue-integrating implants. Our platform material technology, CorNeat EverMatrix™, overcomes the main issue with implants and implantables – the foreign body response they trigger. The EverMatrix™ seamlessly and permanently embeds with live tissue without triggering an inflammatory response. Its durability and flexibility, coupled with its bio-integration capabilities, mark a new era of implants. The EverMatrix™ is set to displace harvested and processed human and animal tissues, including scaffolds and extra cellular matrices, used in a variety of surgical procedures across diversified fields of medicine.
How much funding has CorNeat Vision raised?
CorNeat Vision has raised $18.77M in total funding across 7 rounds. The company is currently at the B stage. Key investors include Guangzhou Sino-Israel Biotech Investment Fund (GIBF), Undisclosed Investor(s).
Who founded CorNeat Vision?
CorNeat Vision was founded in 2015 by Gilad Litvin (Co-founder, Chairman, Chief Medical Officer), Almog Aley-raz (Co-founder & CEO & VP R&D).
What sector is CorNeat Vision in?
CorNeat Vision operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Biomaterials & Tissue Engineering, with core technologies in Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is CorNeat Vision located?
CorNeat Vision is based in 4 HaSheizaf Street, Ra'anana, Israel, Center District.